Skip to main content

Table 7 Benefits and Costs of a Comprehensive CDI Prevention Program 2015–2020 (2015 $) Using Age Adjusted VSL Estimates

From: Assessing the social cost and benefits of a national requirement establishing antibiotic stewardship programs to prevent Clostridioides difficile infection in US hospitals

 

7% discount rate, 10% effectiveness

3% discount rate, 10% effectiveness

7% discount rate, 50% effectiveness

3% discount rate, 50% effectiveness

Total Intervention Costs (in billions)

$3.7

$4.7

$3.3

$4.2

Total Benefits (in billions)

Direct Medical Cost Savings

  Savings in Patient Care Costs

$1.5

$1.8

$7.6

$9.1

  Savings in Expenditures for Antibiotics

$3.8

$4.2

$3.8

$4.2

Benefits of Morbidity Risk Reduction

  Low $/Lost QALY from HCA-CDI

$0.5

$0.4

$2.6

$2.0

  Central $/ Lost QALY from HCA-CDI

$1.0

$0.9

$5.1

$4.3

  High $/ Lost QALY from HCA-CDI

$1.6

$1.3

$7.8

$6.5

Benefits of Mortality Risk Reduction

 Low VSL

  35% Attributable Mortality Proportion

$2.4

$2.0

$12.2

$10.1

  50% Attributable Mortality Proportion

$3.5

$2.9

$17.3

$14.5

 Central VSL

  35% Attributable Mortality Proportion

$5.1

$4.3

$25.5

$21.4

  50% Attributable Mortality Proportion

$7.3

$6.1

$35.0

$30.6

 High VSL

  35% Attributable Mortality Proportion

$7.8

$6.5

$39.0

$32.7

  50% Attributable Mortality Proportion

$11.3

$9.3

$55.7

$46.7

Range of Total Net Benefits

  Low

$4.5 - $5.6

$3.7 - $4.6

$22.9 - $28.0

$21.2 - $25.6

  Central

$7.7 - $9.9

$6.5 - $8.3

$38.7 - $48.2

$34.8 - $44.0

  High

$11.0 - $14.5

$9.1 - $11.9

$54.9 - $71.6

$48.3 - $62.3

  1. HCA-CDI healthcare-associated Clostridioides difficile infection, VSL value of a statistical life, QALY quality-adjusted life year